News – Page 36 – Endpoints News

Lilly, Pfizer invest in UK startup's seed round for neurodegeneration protein degraders

2 months ago

Bristol Myers' MyoKardia unit ends work with Fulcrum; ALX discloses layoffs

2 months ago

FDA puts BioNTech’s malaria vaccine on clinical hold

2 months ago

Live updates: Trump NIH pick Bhattacharya sails through Senate hearing, sidestepping controversy

2 months ago

Updated: Jazz to buy Chimerix to get brain tumor drug five months ahead of PDUFA

2 months ago

Bayer cautions pharma sales dip this year despite major upcoming launches

2 months ago

In an unusual move, Lilly seeks pitches from US states for slice of $27B buildout

2 months ago

UK biotech unveils early data for antibiotic in chronic back pain

2 months ago

China bans imports of Illumina's DNA sequencers following US tariffs

2 months ago

Misleading exhibit booth panel lands NJ drugmaker an untitled letter from FDA

2 months ago

Teladoc holds out for 2026

2 months ago

DOGE terminates lease on FDA quality lab in St. Louis and 29 other sites

2 months ago

PepGen delays study for Duchenne drug as it awaits safety data from another trial

2 months ago

Swiss biotech ends Phase 2 study in Alzheimer's shortly after Lilly and Biogen did the same

2 months ago

Acelyrin rejects buyout offer from Tang’s Concentra, sticks to Alumis merger

2 months ago

Tenaya raises about $53M; BeiGene’s PD-1 gets a first-line approval

2 months ago

Bourla says Pfizer could transfer production to US to sidestep Trump's tariffs

2 months ago

UnitedHealthcare’s copay-only plan is booming, despite backlash over care denials

2 months ago

NIH-backed research tries to use stem cells to restore the eye’s outer layer

3 months ago

23andMe rejects CEO's second take-private offer

3 months ago

Sofinnova Partners raises €1.2B to back another 50 to 60 life sciences startups

3 months ago

Cerebral CEO David Mou has stepped down

3 months ago

GSK, Amgen and AstraZeneca tout Phase 3 data in inflammatory nasal condition

3 months ago

Pliant calls it quits on Phase 2b idiopathic pulmonary fibrosis study

3 months ago

First page Previous page 33 34 353637 38 39 Next page Last page